Regulation of Mitsugumin 29 expression in muscle physiology and diseases

Mitsugumin 29 表达在肌肉生理学和疾病中的调节

• 批准号: 10020756
• 负责人: Hua Zhu
• 金额: $ 32.76万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-04-01 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10020756
• 关键词: 3' Untranslated Regions; Ablation; Address; Animal Model; Appearance; Binding Sites; Biochemical; Biogenesis; Biological Assay; Biological Process; Biopsy; Cell Culture Techniques; Cell Line; Cells; Coupling; DYSF gene; Data; Development; Direct Lytic Factors; Down-Regulation; Electron Microscopy; Exhibits; Gene Delivery; Genes; Genetic; Goals; Human; Immunoblotting; Immunohistochemistry; In Vitro; Injury; Link; Maintenance; Mediating; Membrane; MicroRNAs; Modeling; Molecular; Mus; Muscle; Muscle Development; Muscle Fibers; Muscular Dystrophies; Mutagenesis; Myoblasts; Myopathy; Names; Patients; Physiological; Play; Post-Transcriptional Regulation; Principal Investigator; Process; Protein Family; Proteins; RNA; Regulation; Research; Research Design; Research Personnel; Role; Sarcolemma; Signal Transduction; Skeletal Muscle; Stress; Structure; Synaptophysin; System; Testing; Therapeutic; Transgenic Animals; Transgenic Mice; Tubular formation; experimental study; improved; in vivo; insight; mdx mouse; member; mouse model; muscle physiology; muscle regeneration; muscle strength; professor; public health relevance; regenerative; tool

 DESCRIPTION (provided by applicant): Mitsugumin 29 (MG29) is a muscle-specific member of the synaptophysin family proteins that participates in controlling the maturation and development of the transverse-tubule (TT) structure and the maintenance of intracellular Ca2+ signaling in skeletal muscle. Genetic ablation of mg29 leads to defective TT structure in skeletal muscle, which show similarity to the abnormal TT network observed in animal models of, and human patients with, muscular dystrophy. The principal investigator of this application has obtained evidence that revealed an essential role for MG29 in controlling the TT membrane network in muscle physiology and diseases. Immunoblot showed that expression of MG29 was reduced in both human and mice with muscular dystrophy, indicating the possibility that MG29 may be involved in the development of muscular dystrophy. Using biochemical assay, we identified a functional interaction between MG29, dysferlin and Bin1, other TT- resident proteins with important roles in muscular dystrophy. Toward understanding the biological function for MG29 in control of TT biogenesis, we used the HMCL-7304 myoblast cell line derived from human muscle. Cultured myotubes derived from HMCL-7304 cells do not express MG29 and lack TT network. Preliminary study with rescue of MG29 in HMCL-7304 myotubes revealed the initiation of TT membranes. Establishing an in vitro system with control of TT membrane can potentially be a useful tool for muscle physiology research. The mg29 gene contains a unique 3' untranslated region (UTR) with potential binding sites for microRNA (miRNA) or RNA-stabilizing factors. Mutagenesis studies revealed that miR-181a could target a region in the 3'UTR that is highly conserved between mouse and human mg29 genes to exhibit a strong control of MG29 expression in skeletal muscle. Studies from other investigators have shown that miR-181 was significantly elevated in human patients with muscular dystrophy. These data suggest an intriguing possibility that elevated miR-181a may be a contributing factor for the reduced MG29 expression under muscular dystrophic conditions. Experiments outlined in this proposal will focus on testing the hypothesis that "MG29 is an integral component of TT biogenesis in skeletal muscle, and miRNA-mediated control of MG29 expression contributes to changes in TT integrity during muscular dystrophy". First, by using in vitro cell culture and in vivo transgenic animal approaches, we will discern the biological function for MG29 in control of TT integrity and remodeling in muscle physiology and dystrophy. Second, we will elucidate the mechanisms that underlie miRNA-mediated control of MG29 expression in skeletal muscle, and to identify the mechanisms that contribute to reduction of MG29 in dystrophic muscle. Using AAV-mediated gene delivery of antagomir into the mdx mice, we will test whether suppression of miRNA-mediated down-regulation of MG29 expression can improve TT structure and rescue muscle strength in dystrophic muscle.



项目成果

Cancer immune checkpoint blockade therapy and its associated autoimmune cardiotoxicity.

癌症免疫检查点阻断疗法及其相关的自身免疫心脏毒性。

• DOI: 10.1038/s41401-018-0062-2
• 发表时间: 2018
• 期刊: Acta pharmacologica Sinica
• 影响因子: 8.2
• 作者: Zhang,Jiu-Cheng;Chen,Wei-Dong;Alvarez,JeanBustamante;Jia,Kelly;Shi,Lei;Wang,Qiang;Zou,Ning;He,Kai;Zhu,Hua
• 通讯作者: Zhu,Hua

Regulation of Myogenesis by a Na/K-ATPase α1 Caveolin-Binding Motif.

• DOI: 10.1093/stmcls/sxab012
• 发表时间: 2022-03-16
• 期刊: Stem cells (Dayton, Ohio)
• 作者: Huang M;Wang X;Banerjee M;Mukherji ST;Kutz LC;Zhao A;Sepanski M;Fan CM;Zhu GZ;Tian J;Wang DZ;Zhu H;Xie ZJ;Pierre SV;Cai L
• 通讯作者: Cai L

UCHL1 protects against ischemic heart injury via activating HIF-1α signal pathway.

• DOI: 10.1016/j.redox.2022.102295
• 发表时间: 2022-06
• 期刊: Redox biology
• 影响因子: 11.4
• 作者: Geng B;Wang X;Park KH;Lee KE;Kim J;Chen P;Zhou X;Tan T;Yang C;Zou X;Janssen PM;Cao L;Ye L;Wang X;Cai C;Zhu H
• 通讯作者: Zhu H

UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.

• DOI: 10.1002/jcb.26232
• 发表时间: 2018-01
• 期刊: Journal of cellular biochemistry
• 影响因子: 4
• 作者: Luo Y;He J;Yang C;Orange M;Ren X;Blair N;Tan T;Yang JM;Zhu H
• 通讯作者: Zhu H

Regulation of multidrug resistance by microRNAs in anti-cancer therapy.

抗癌治疗中microRNA对多药耐药性的调节

• DOI: 10.1016/j.apsb.2016.09.002
• 发表时间: 2017-01
• 期刊: Acta pharmaceutica Sinica. B
• 作者: An X;Sarmiento C;Tan T;Zhu H
• 通讯作者: Zhu H